The U.S. Food and Drug Administration (FDA) announced that it authorized marketing of software to help medical professionals acquire cardiac ultrasound images. The approved software, called Caption Guidance, is an accessory to diagnostic ultrasound systems and utilises artificial intelligence (AI) to assist the user capture images of a patient's heart. These images are used in the diagnosis of various cardiac conditions of adult patients. The FDA representative said the marketing authorization is groundbreaking because it enables medical practitioners who may not be experts in ultrasonography to access safe and effective a diagnostics tool that demonstrates the capability of AI and machine learning.
Cadastre-se agora para Ações Semanais de Promoção
100% free, Unsubscribe any time!Add 1: Room 605 6/F FA YUEN Commercial Building, 75-77 FA YUEN Street, Mongkok KL, HongKong Add 2: Room 405, Building E, MeiDu Building, Gong Shu District, Hangzhou City, Zhejiang Province, China
Whatsapp/Tel: +8618057156223 Tel: 0086 571 86729517 Tel em HK: 00852 66181601
Email: [email protected]